COMMUNIQUÉS West-GlobeNewswire

Inotiv Provides Notice Regarding Cybersecurity Incident
13/02/2026
WEST LAFAYETTE, Ind., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and [...]
Paretofit Launches Digital Health Coaching System for Entrepreneurs in Europe’s DACH Region
13/02/2026
Built on a proven 98.1% success rate, the evidence-based 80/20 approach is now available online – tailored for self-employed professionals and entrepreneurs in Germany, Austria, and Switzerland. Cologne, Germany, Feb. [...]
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Nasdaq Minimum Bid Price Requirement
13/02/2026
DUBLIN, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, [...]
Psyence BioMed Approves Put Option Agreement with PsyLabs to Secure Strategic Supply and Strengthen Commercialization Pathway
14/02/2026
The Put Option Agreement positions Psyence BioMed for potential significant future equity participation in one of the world's most advanced psychedelic pharmaceutical grade manufacturers, thereby securing predictable [...]
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13/02/2026
NEW HOPE, Pa., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through [...]
Natural Alternatives International, Inc. Announces 2026 Q2 and YTD Results
13/02/2026
CARLSBAD, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today [...]
Edesa Biotech Reports Fiscal 1st Quarter 2026 Results
13/02/2026
TORONTO, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported [...]
Romeo Orthopaedics Hosts Successful Open House Event
13/02/2026
Community Engages with Leading Orthopaedic Expert at Burr Ridge Clinic Burr Ridge, ILLINOIS, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Romeo Orthopaedics , a leader in specialized care for shoulder and elbow conditions, [...]
Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents
13/02/2026
CINCINNATI, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed’s existing [...]
AVITA Medical to Host Investor Webinar Briefing
13/02/2026
VALENCIA, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders and prospective [...]
Solana Company (NASDAQ: HSDT) Becomes First Digital Asset Treasury to Enable Borrowing Against Natively Staked SOL in Qualified Custody
13/02/2026
Solana Company (HSDT), Anchorage Digital, and Kamino collaborate to bring institutional capital to Solana's high-performance DeFi ecosystem through a first-of-its-kind tri-party custody model Institutions earn staking [...]
Precision Optics Schedules Second Quarter of Fiscal Year 2026 Conference Call for February 17, 2026
13/02/2026
GARDNER, Mass., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/ [...]
Valneva fait un point sur l’utilisation du vaccin IXCHIQ® au Royaume-Uni
13/02/2026
Lyon (France), le 13 février 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd’hui qu’à la suite d’une revue des bénéfices et risques du vaccin contre le [...]
Valneva Provides Update on Recommendations for Use of IXCHIQ® in the United Kingdom
13/02/2026
Lyon (France), February 13, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that following a review of the benefits and risks of the Company’s single‑dose chikungunya [...]
Opus Genetics Announces $25 Million Private Placement
13/02/2026
RESEARCH TRIANGLE PARK, N.C., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc . (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore [...]
Netramark Announces Uplisting to Toronto Stock Exchange
13/02/2026
TORONTO, Feb. 13, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) , a company focused on AI-driven clinical trial optimization and precision [...]
Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies
13/02/2026
Collaboration with Mayo Clinic aims to accelerate regulatory approval and commercialization of Lumee™ wearable continuous tissue oxygen monitoring product Seeking to develop and commercialize new tethered continuous [...]
Conavi Medical Highlights Peer-Reviewed Publication Demonstrating Advantages of Hybrid IVUS-OCT Imaging
13/02/2026
- New Academic Data Supports Clinical and Commercial Value of Hybrid Imaging Platform- TORONTO, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (“Conavi” or the “Company”), a leader in hybrid intravascular [...]
Beyond Air® Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update
13/02/2026
Increased revenue by 105% year-over-year (YoY) to $2.2 million in fiscal Q3 Maintain fiscal year 2026 revenue guidance of $8-10 million $22.3 million pro forma cash, cash equivalents, restricted cash and marketable [...]

Pages